BeyondSpring Inc (BYSI):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BeyondSpring Inc (BYSI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8128
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BeyondSpring Inc (BeyondSpring) is a clinical stage biopharmaceutical company focused on the development of immune-oncology cancer therapies. The company offers lead compound, Plinabulin, is derived from a natural compound which holds a number of biochemical activities and provides multiple potential therapeutic potentials in various types of cancers; BPI-002, an oral small molecule agent used for the treatment of colon cancer; BPI-003 and BPI-004 against various tumors. Its target areas include non-small cell lung cancer, neutropenia prevention, and plinabulin + nivolumab. The company holds a license from the Fred Hutchinson Cancer Research Center and University of Washington for a range of platform technology which concentrates on a novel mechanism to inhibit a various oncogenes. BeyondSpring is headquartered in New York, the US.

BeyondSpring Inc (BYSI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
BeyondSpring Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
BeyondSpring Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
BeyondSpring Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
BeyondSpring Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
BeyondSpring Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BeyondSpring Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
BeyondSpring Pharma Acquires Rights to Plinabulin from Nereus Pharma 11
Venture Financing 12
BeyondSpring Pharma Raises USD20 Million in Series A Financing 12
Private Equity 13
BeyondSpring Pharma Raises USD15.3 Million in Equity Financing 13
Partnerships 14
BeyondSpring Pharma Enters into Agreement with Fred Hutchinson Cancer Research Center 14
Equity Offering 15
BeyondSpring to Raise USD20 in Private Placement of Shares 15
BeyondSpring Prices Private Placement of Shares for USD50.8 Million 16
BeyondSpring Prices IPO for USD3.5 Million 18
BeyondSpring Inc – Key Competitors 20
BeyondSpring Inc – Key Employees 21
BeyondSpring Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Jun 21, 2018: BeyondSpring Provides Operational Updates and First-Quarter 2018 Financial Results 23
Apr 03, 2018: BeyondSpring Provides Operational Update and Fourth-Quarter and Full-Year 2017 Financial Results 25
Nov 09, 2017: BeyondSpring Reports Third Quarter 2017 Operational and Financial Results 27
Aug 21, 2017: BeyondSpring Provides Operational Update for Second Quarter of 2017 28
May 22, 2017: BeyondSpring Reports First Quarter 2017 Financial Results 30
Apr 28, 2017: BeyondSpring Provides Quarterly Operational Update and Full Year 2016 Results 32
Corporate Communications 35
Aug 01, 2018: Beyondspring appoints Richard J. Daly as chief operating officer to lead the transition to commercialization 35
Mar 27, 2018: BeyondSpring Names Edward Dongheng Liu As Chief Financial Officer 36
Jan 03, 2018: BeyondSpring Appoints Life Sciences Veteran Patrick Fabbio to Board of Directors as an Independent Member 37
Product News 38
01/10/2017: BeyondSpring to Present at Biotech Showcase 2017 During Annual JPMorgan Healthcare Conference on January 10 in San Francisco 38
Product Approvals 39
Jan 24, 2017: FDA Accepts BeyondSpring IND Application for Plinabulin for the Prevention of Chemotherapy-Induced Neutropenia 39
Clinical Trials 40
Feb 21, 2017: BeyondSprings Promising Clinical Data for Lead Asset on Non-Small Cell Lung Cancer Treatment Selected for Presentation at 2017 ASCO-SITC Clinical Immuno-Oncology Symposium 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
BeyondSpring Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
BeyondSpring Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
BeyondSpring Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
BeyondSpring Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
BeyondSpring Inc, Deals By Therapy Area, 2012 to YTD 2018 9
BeyondSpring Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BeyondSpring Pharma Acquires Rights to Plinabulin from Nereus Pharma 11
BeyondSpring Pharma Raises USD20 Million in Series A Financing 12
BeyondSpring Pharma Raises USD15.3 Million in Equity Financing 13
BeyondSpring Pharma Enters into Agreement with Fred Hutchinson Cancer Research Center 14
BeyondSpring to Raise USD20 in Private Placement of Shares 15
BeyondSpring Prices Private Placement of Shares for USD50.8 Million 16
BeyondSpring Prices IPO for USD3.5 Million 18
BeyondSpring Inc, Key Competitors 20
BeyondSpring Inc, Key Employees 21
BeyondSpring Inc, Subsidiaries 22

List of Figures
BeyondSpring Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BeyondSpring Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BeyondSpring Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BeyondSpring Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BeyondSpring Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
BeyondSpring Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
BeyondSpring Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
BeyondSpring Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

★海外企業調査レポート[BeyondSpring Inc (BYSI):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hokka Hokka:企業の戦略・SWOT・財務分析
    Hokka Hokka - Strategy, SWOT and Corporate Finance Report Summary Hokka Hokka - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • TRACOE medical GmbH:企業の戦略的SWOT分析
    TRACOE medical GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • S-Oil Corporation Inc (010950):企業の財務・戦略的SWOT分析
    S-Oil Corporation Inc (010950) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Realtek Semiconductor Corp. (2379):企業の財務・戦略的SWOT分析
    Realtek Semiconductor Corp. (2379) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Westwater Resources, Inc.:企業のM&A・事業提携・投資動向
    Westwater Resources, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Westwater Resources, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Selective Insurance Group, Inc. (SIGI):企業の財務・戦略的SWOT分析
    Selective Insurance Group, Inc. (SIGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • ReShape Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary ReShape Medical Inc (ReShape Medical), a subsidiary of EnteroMedics Inc is a medical device company that offers weight loss solutions. The company provides dual intragastric balloon for weight loss. Its product comprises of ReShape Duo, a non surgical dual-intragastric balloon used in the tr …
  • Avon Rubber Plc (AVON):企業の財務・戦略的SWOT分析
    Avon Rubber Plc (AVON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Nordic Nanovector ASA (NANO):製薬・医療:M&Aディール及び事業提携情報
    Summary Nordic Nanovector ASA (Nordic Nanovector), formerly Nordic Nanovector AS is a developer and commercializer of antibody radionuclide conjugates for the treatment of haematological cancers. The company’s lead product candidate includes Betalutin, an antibody radionuclide conjugate developed fo …
  • Frigo Pak Gida Maddeleri Sanayi ve Tic.:企業の戦略・SWOT・財務分析
    Frigo Pak Gida Maddeleri Sanayi ve Tic. - Strategy, SWOT and Corporate Finance Report Summary Frigo Pak Gida Maddeleri Sanayi ve Tic. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Cavion LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Cavion LLC (Cavion), formerly Tau Therapeutics LLC is a clinical stage pharmaceutical company that develops modulators and drugs. The company researches and develops T-type calcium channel (Cav3) inhibitors for the treatment of neurologic and oncologic diseases. It provides pipeline products …
  • Bilfinger Tebodin BV:企業の戦略的SWOT分析
    Bilfinger Tebodin BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • ThyssenKrupp AG:企業のM&A・事業提携・投資動向
    ThyssenKrupp AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ThyssenKrupp AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • National Fuel Gas Co Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    National Fuel Gas Co Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary National Fuel Gas Co (National Fuel) is a diversified energy company that specializes in the production, gathering, transportation, distribution and marketing of natural gas. It operates as an integ …
  • Coca-Cola HBC-Srbija d.o.o.:企業の戦略・SWOT・財務情報
    Coca-Cola HBC-Srbija d.o.o. - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola HBC-Srbija d.o.o. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Gencor Nutrients, Inc.:企業の戦略・SWOT・財務情報
    Gencor Nutrients, Inc. - Strategy, SWOT and Corporate Finance Report Summary Gencor Nutrients, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Paliburg Holdings Limited:戦略・SWOT・企業財務分析
    Paliburg Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Paliburg Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Camping World Holdings, Inc. (CWH):企業の財務・戦略的SWOT分析
    Camping World Holdings, Inc. (CWH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Alfa Laval AB (ALFA):石油・ガス:M&Aディール及び事業提携情報
    Summary Alfa Laval AB (Alfa Laval) is a provider of specialized products and solutions for heat transfer, separation and fluid handling. Its product portfolio includes centrifuges, pumps and valves, heat exchangers, thermal fluid systems, boilers, decanters, burners, evaporation systems, high speed …
  • Yes Bank Wealth Management:企業の戦略・SWOT・財務情報
    Yes Bank Wealth Management - Strategy, SWOT and Corporate Finance Report Summary Yes Bank Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆